Search | Sngine

Pratiksha Dhote added blog Health
2025-12-13 11:05:58 -

Analytical Biosimilar Market Data: Ensuring Equivalence and Optimizing Use Cases for Delivery Devices Names in Chronic Conditions
The foundation of the Biosimilars Market Data is the comprehensive analytical comparison required to demonstrate 'fingerprint-like' similarity between the biosimilar and the reference biologic. This meticulous data, generated using advanced specific technologies like mass spectrometry and various bioassays, is the core evidence presented to regulatory bodies to secure approval. The use cases...

0 Comments 0 Shares 144 Views 0 Reviews

Please log in to like, share and comment!
Anuj Mrfr added blog Health
2026-01-22 10:33:20 -

Biosimilar Bevacizumab Market: Is 2026 the Era of "Ophthalmic-Specific" Bevacizumab to End Off-Label Risks?
In 2026, the market is witnessing the rise of bevacizumab formulations specifically designed for the eye. In 2026, the market is identifying "Intravitreal Innovation" as a high-growth driver for the Biosimilar Bevacizumab Market, moving away from the "repackaged" oncology vials that have historically posed a risk of bacterial endophthalmitis. This 2026 movement is significant because companies...

0 Comments 0 Shares 46 Views 0 Reviews

Please log in to like, share and comment!
Kajal Khomane added blog Other
2026-02-13 10:03:41 -

Biosimilar Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
"Global Executive Summary Biosimilar Market: Size, Share, and Forecast The global biosimilar market size was valued at USD 64.93 billion in 2024 and is expected to reach USD 598.55 billion by 2032, at a CAGR of 32.00% during the forecast periodThe market expansion is primarily driven by the growing number of patent expiries of blockbuster biologics and the rising prevalence of chronic...

0 Comments 0 Shares 7 Views 0 Reviews

Please log in to like, share and comment!
Kajal Khomane added blog Other
2026-01-14 08:41:58 -

Biosimilar Market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis
"Regional Overview of Executive Summary Biosimilar Market by Size and Share The global biosimilar market size was valued at USD 64.93 billion in 2024 and is expected to reach USD 598.55 billion by 2032, at a CAGR of 32.00% during the forecast periodThe market expansion is primarily driven by the growing number of patent expiries of blockbuster biologics and the rising prevalence of...

0 Comments 0 Shares 96 Views 0 Reviews

Please log in to like, share and comment!
Pratiksha Dhote added blog Health
2025-12-13 10:41:17 -

The Maturing Segment: Assessing TNF-α Antagonists Product Types, Patent Expiries, and the Market Trend toward Biosimilar Adoption
The Tumor Necrosis Factor-alpha (TNF-α) Antagonists represent the most established and largest segment within the biological product types used for Rheumatoid Arthritis. Having revolutionized treatment decades ago, these injectable therapies have a wealth of clinical data supporting their efficacy and long-term use cases in moderate-to-severe disease. However, this segment is now reaching...

0 Comments 0 Shares 153 Views 0 Reviews

Please log in to like, share and comment!